Screener
MiniMed Group MMED CGM — Net Sales
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by MiniMed Group in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: MiniMed Group’s 10-Q, filed April 17, 2026.
- Filed
- Apr 17, 2026, 4:29 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-025777
FAQ
- What is MiniMed Group's CGM — net sales?
- MiniMed Group (MMED) reported CGM — net sales of $390M in Q1 2026.
- How has MiniMed Group's CGM — net sales changed year-over-year?
- MiniMed Group's CGM — net sales increased by 18.2% year-over-year, from $330M to $390M.
- What does CGM — net sales mean?
- This metric represents the total revenue generated from the sale of continuous glucose monitoring hardware, sensors, and associated digital monitoring subscriptions. It serves as a key indicator of market adoption for real-time glucose tracking technology within the diabetes management portfolio. Growth in this segment reflects the company's ability to capture market share in the shift toward automated and data-driven patient care solutions.
Ask your AI about MiniMed Group's cgm — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude